Cargando…
Cell-mediated targeting drugs delivery systems
Drug delivery systems have shown tremendous promise to improve the diagnostic and therapeutic effects of drugs due to their special property. Targeting tissue damage, tumors, or drugs with limited toxicity at the site of infection is the goal of successful pharmaceuticals. Targeted drug delivery has...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7594730/ https://www.ncbi.nlm.nih.gov/pubmed/33096949 http://dx.doi.org/10.1080/10717544.2020.1831103 |
_version_ | 1783601695064850432 |
---|---|
author | Yu, Hongli Yang, Zhihong Li, Fei Xu, Lisa Sun, Yong |
author_facet | Yu, Hongli Yang, Zhihong Li, Fei Xu, Lisa Sun, Yong |
author_sort | Yu, Hongli |
collection | PubMed |
description | Drug delivery systems have shown tremendous promise to improve the diagnostic and therapeutic effects of drugs due to their special property. Targeting tissue damage, tumors, or drugs with limited toxicity at the site of infection is the goal of successful pharmaceuticals. Targeted drug delivery has become significantly important in enhancing the pharmaceutical effects of drugs and reducing their side effects of therapeutics in the treatment of various disease conditions. Unfortunately, clinical translation of these targeted drug delivery system mechanisms faces many challenges. At present, only a few targeted drug delivery systems can achieve high targeting efficiency after intravenous injection, even though numerous surface markers and targeting approaches have been developed. Thus, cell-mediated drug-delivery targeting systems have received considerable attention for their enhanced therapeutic specificity and efficacy in the treatment of the disease. This review highlights the recent advances in the design of the different types of cells that have been explored for cell-mediated drug delivery and targeting mechanisms. A better understanding of cell biology orientation and a new generation of delivery strategies that utilize these endogenous approaches are expected to provide better solutions for specific site delivery and further facilitate clinical translation. |
format | Online Article Text |
id | pubmed-7594730 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Taylor & Francis |
record_format | MEDLINE/PubMed |
spelling | pubmed-75947302020-11-10 Cell-mediated targeting drugs delivery systems Yu, Hongli Yang, Zhihong Li, Fei Xu, Lisa Sun, Yong Drug Deliv Research Article Drug delivery systems have shown tremendous promise to improve the diagnostic and therapeutic effects of drugs due to their special property. Targeting tissue damage, tumors, or drugs with limited toxicity at the site of infection is the goal of successful pharmaceuticals. Targeted drug delivery has become significantly important in enhancing the pharmaceutical effects of drugs and reducing their side effects of therapeutics in the treatment of various disease conditions. Unfortunately, clinical translation of these targeted drug delivery system mechanisms faces many challenges. At present, only a few targeted drug delivery systems can achieve high targeting efficiency after intravenous injection, even though numerous surface markers and targeting approaches have been developed. Thus, cell-mediated drug-delivery targeting systems have received considerable attention for their enhanced therapeutic specificity and efficacy in the treatment of the disease. This review highlights the recent advances in the design of the different types of cells that have been explored for cell-mediated drug delivery and targeting mechanisms. A better understanding of cell biology orientation and a new generation of delivery strategies that utilize these endogenous approaches are expected to provide better solutions for specific site delivery and further facilitate clinical translation. Taylor & Francis 2020-10-23 /pmc/articles/PMC7594730/ /pubmed/33096949 http://dx.doi.org/10.1080/10717544.2020.1831103 Text en © 2020 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Yu, Hongli Yang, Zhihong Li, Fei Xu, Lisa Sun, Yong Cell-mediated targeting drugs delivery systems |
title | Cell-mediated targeting drugs delivery systems |
title_full | Cell-mediated targeting drugs delivery systems |
title_fullStr | Cell-mediated targeting drugs delivery systems |
title_full_unstemmed | Cell-mediated targeting drugs delivery systems |
title_short | Cell-mediated targeting drugs delivery systems |
title_sort | cell-mediated targeting drugs delivery systems |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7594730/ https://www.ncbi.nlm.nih.gov/pubmed/33096949 http://dx.doi.org/10.1080/10717544.2020.1831103 |
work_keys_str_mv | AT yuhongli cellmediatedtargetingdrugsdeliverysystems AT yangzhihong cellmediatedtargetingdrugsdeliverysystems AT lifei cellmediatedtargetingdrugsdeliverysystems AT xulisa cellmediatedtargetingdrugsdeliverysystems AT sunyong cellmediatedtargetingdrugsdeliverysystems |